Nathaniel left Harvard senior year to work on Nivien Therapeutics. He was a partner at Dorm Room Fund and part of the new-co formation team at RA Capital. He studied age-related diseases in the Chad Cowan Lab at the Harvard Stem Cell Institute and the David Sinclair Lab at Harvard Medical School.

NATHANIEL BROOKS HORWITZ
Chief Executive Officer